Koers Canopy Rivers Inc Toronto S.E.
Aandelen
CA1380411084
Farmaceutische producten
Omzet 2022 | 1,9 mln. 1,39 mln. 1,29 mln. | Omzet 2023 | 7,4 mln. 5,41 mln. 5,02 mln. | Marktkapitalisatie | 10,76 mln. 7,86 mln. 7,31 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -52 mln. -38,01 mln. -35,32 mln. | Nettowinst (verlies) 2023 | -85 mln. -62,13 mln. -57,73 mln. | EV/omzet 2022 | -144 x |
Nettoliquiditeiten 2022 | 298 mln. 217 mln. 202 mln. | Nettoschuld 2023 | 42,14 mln. 30,8 mln. 28,62 mln. | EV/omzet 2023 | 7,15 x |
K/w-verhouding 2022 |
-0,42
x | K/w-verhouding 2023 |
-0,13
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 84,53% |
Recentste transcriptie over Canopy Rivers Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mike Totzke
CEO | Chief Executive Officer | - | 20-06-22 |
Eddie Lucarelli
DFI | Director of Finance/CFO | - | 01-03-18 |
Amanda Rico
HRO | Human Resources Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 39 | 30-09-21 | |
Richard Mavrinac
BRD | Director/Board Member | 71 | 17-09-18 |
Chairman | - | 17-09-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,09% | 6,16 mld. | |
-16,34% | 4,46 mld. | |
-7,11% | 3,27 mld. | |
+5,14% | 3,2 mld. | |
-0,18% | 2,6 mld. | |
+47,93% | 1,98 mld. | |
-7,15% | 1,7 mld. | |
+0,67% | 1,66 mld. | |
-8,73% | 1,61 mld. |